CLSDQ
Clearside Biomedical, Inc.Company with tickers: CLSDQ
CIK
1539029
CUSIP
185063203
Shares Outstanding
5,233,981
13F Activity (30d)
1 filings
1 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,358,000 | USD | 2024-09-30 | 10-Q | 2025-11-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $14,346,000 | USD | 2024-09-30 | 10-Q | 2025-11-14 |
| Operating Income | $-21,733,000 | USD | 2024-09-30 | 10-Q | 2025-11-14 |
| Net Income | $-4,495,000 | USD | 2025-06-30 | 10-Q | 2025-11-14 |
| EPS (Basic) | $-5.55 | USD/shares | 2024-09-30 | 10-Q | 2025-11-14 |
| EPS (Diluted) | $-5.55 | USD/shares | 2024-09-30 | 10-Q | 2025-11-14 |